Contract HHSD200200930162C
Emergent Biodefense Operations Lansing Llc · Department Of Health And Human Services · June 22, 2009
Emergent Biodefense Operations Lansing Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on June 22, 2009 for $497.41 million of work in biological product (except diagnostic) manufacturing. Performance is in Atlanta, GA. It was awarded under full and open competition. The contract has been modified 17 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 20, 2013.
Contract details
- PIID
- HHSD200200930162C
- Award type
- Dca
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Atlanta, GA
- First action
- June 22, 2009
- Latest action
- June 20, 2013
Description
AVA
Modification timeline
-
June 20, 2013Mod 18$0
-
June 4, 2013Mod 17$-8.88M
-
December 5, 2011Mod 16$0
-
September 30, 2011Mod 14$0
-
September 30, 2011Mod 15$0
-
September 23, 2011Mod 13$0
-
May 25, 2011Mod 12$100.61M
-
November 23, 2010Mod 11$0
-
September 10, 2010Mod 10$0
-
July 16, 2010Mod 9$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD200200930162C?
Contract HHSD200200930162C is a federal contract awarded to Emergent Biodefense Operations Lansing Llc by Department Of Health And Human Services on June 22, 2009 for $497.41 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 17 times since the base award.
Who won contract HHSD200200930162C?
Emergent Biodefense Operations Lansing Llc won contract HHSD200200930162C from Department Of Health And Human Services.
How much is contract HHSD200200930162C worth?
Contract HHSD200200930162C has obligated $497.41 million to date.